US president has said that he will use tariffs to bring down costly pharmaceutical drugs, but the impact remains uncertain.
Save
Share
United States President Donald Trump has signed an executive order that could slap long-threatened tariffs of up to 100 percent on some patented drugs if pharmaceutical companies don’t reach deals with his administration in the coming months.
Under Thursday’s executive order, companies that have signed a “most favoured nation” pricing deal and are actively building facilities in the US will have a zero-percent tariff.
